AIG
OBIO icon

American International Group’s Orchestra BioMed OBIO Stock Holding History

American International Group’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,181
Closed -$37.8K – 1835
2024
Q1 		$37.8K Sell
7,181
-62
-0.9% -$420 ﹤0.01% 2837
2023
Q4 		$66.1K Sell
7,243
-28
-0.4% -$191 ﹤0.01% 2747
2023
Q3 		$63.4K Buy
7,271
+5,255
+261% +$35.3K ﹤0.01% 2754
2023
Q2 		$14.1K Buy
+2,016
New +$30.6K ﹤0.01% 3036

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American International Group's OBIO Position: Q2 2024 in Review

American International Group sold out of Orchestra BioMed (OBIO) in Q2 2024, closing a stake of 7,181 shares — an estimated $37.8K sold.

American International Group first reported a position in OBIO in Q2 2023 and held it in 4 quarters. The position peaked at $66.1K in Q4 2023. 47 funds tracked by Wall St. Rank hold OBIO as of Q2 2024.

  • American International Group reported no remaining Orchestra BioMed position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 7,181 Orchestra BioMed shares in Q2 2024, an estimated $37.8K.
  • American International Group first reported a position in Orchestra BioMed in Q2 2023 and held it in 4 quarters.
  • American International Group's Orchestra BioMed position peaked at $66.1K in Q4 2023.
  • 47 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.